184 related articles for article (PubMed ID: 25432928)
1. Reforming the cancer drug fund.
Buxton M; Longworth L; Raftery J; Sculpher M; Towse A
BMJ; 2014 Nov; 349():g7276. PubMed ID: 25432928
[No Abstract] [Full Text] [Related]
2. MPs find no evidence that Cancer Drugs Fund was spent wisely.
Hawkes N
BMJ; 2016 Feb; 352():i755. PubMed ID: 26850036
[No Abstract] [Full Text] [Related]
3. New "managed access" process for Cancer Drugs Fund to go ahead, NHS England confirms.
Mayor S
BMJ; 2016 Feb; 352():i1208. PubMed ID: 26926879
[No Abstract] [Full Text] [Related]
4. Cancer Drugs Fund of minimal benefit.
Burki TK
Lancet Oncol; 2017 Jun; 18(6):e305. PubMed ID: 28483412
[No Abstract] [Full Text] [Related]
5. NHS will not pay for drugs that offer little clinical benefit, says cancer fund boss.
Kmietowicz Z
BMJ; 2015 Jan; 350():h125. PubMed ID: 25569117
[No Abstract] [Full Text] [Related]
6. Cost of hospital prescribing rose 15% in a year owing to new rheumatoid arthritis and cancer drugs.
Hawkes N
BMJ; 2014 Nov; 349():g6867. PubMed ID: 25404423
[No Abstract] [Full Text] [Related]
7. At last, NICE to take over the Cancer Drugs Fund.
Timmins N
BMJ; 2016 Mar; 352():i1324. PubMed ID: 26951838
[No Abstract] [Full Text] [Related]
8. UK Cancer Drugs Fund to reassess 42 agents.
Cagney H
Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638560
[No Abstract] [Full Text] [Related]
9. Most drugs paid for by £1.27bn Cancer Drugs Fund had no "meaningful benefit".
Cohen D
BMJ; 2017 Apr; 357():j2097. PubMed ID: 28455308
[No Abstract] [Full Text] [Related]
10. Cancer Drugs Fund 2.0: A Missed Opportunity?
McCabe C; Paul A; Fell G; Paulden M
Pharmacoeconomics; 2016 Jul; 34(7):629-33. PubMed ID: 27002519
[No Abstract] [Full Text] [Related]
11. Should clinicians have a role in financial decision making in the NHS?
Ahmed F; Ahmed N; Lechler R; Briggs TR
Br J Hosp Med (Lond); 2017 Jul; 78(7):366-367. PubMed ID: 28692357
[No Abstract] [Full Text] [Related]
12. The breast alternative?
Chudley P
Nurs Times; 1989 Aug 16-22; 85(33):22-3. PubMed ID: 2780344
[No Abstract] [Full Text] [Related]
13. Conservatism and the cancer drugs fund.
Hopkinson NS
BMJ; 2017 May; 357():j2451. PubMed ID: 28539426
[No Abstract] [Full Text] [Related]
14. Financial crisis is inevitable in the NHS by 2015-16, King's Fund says.
Iacobucci G
BMJ; 2014 May; 348():g3048. PubMed ID: 24789278
[No Abstract] [Full Text] [Related]
15. NICE and the Cancer Drugs Fund--2020 vision?
Drug Ther Bull; 2016 Apr; 54(4):37. PubMed ID: 27056193
[No Abstract] [Full Text] [Related]
16. The New and Non-Transparent Cancer Drugs Fund.
Wood EM; Hughes DA
Pharmacoeconomics; 2020 Jan; 38(1):1-4. PubMed ID: 31828737
[No Abstract] [Full Text] [Related]
17. Trusts have used part of £700m winter pressures fund to pay off debts, doctors claim.
Iacobucci G
BMJ; 2015 Mar; 350():h1231. PubMed ID: 25740844
[No Abstract] [Full Text] [Related]
18. Challenges for the new Cancer Drugs Fund.
Littlejohns P; Weale A; Kieslich K; Wilson J; Rumbold B; Max C; Rid A
Lancet Oncol; 2016 Apr; 17(4):416-418. PubMed ID: 26948924
[No Abstract] [Full Text] [Related]
19. Paying for cancer care - a new dilemma.
Sikora K
J R Soc Med; 2007 Apr; 100(4):166-9. PubMed ID: 17404337
[No Abstract] [Full Text] [Related]
20. Careful use of science to advance the debate on the UK Cancer Drugs Fund.
Lakdawalla DN; Jena AB; Doctor JN
JAMA; 2014 Jan; 311(1):25-6. PubMed ID: 24381964
[No Abstract] [Full Text] [Related]
[Next] [New Search]
